Congenital transcobalamin II deficiency due to errors in RNA editing

Blood Cells, Molecules, and Diseases

Volumn 28, Issue 2, 2002, Pages 134-142

  Qian, Lian ^a   Quadros, Edward V ^a   Regec, Annette ^a   Zittoun, Jacqueline ^b   Rothenberg, Sheldon P ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b Laboratoire Central d'Hematologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYANOCOBALAMIN; DNA FRAGMENT; FOLIC ACID; GENOMIC DNA; TRANSCOBALAMIN II; MESSENGER RNA; TRANSCOBALAMIN;

APLASTIC ANEMIA; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CELL TRANSPORT; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DISEASE COURSE; FEMALE; FIBROBLAST; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LABORATORY TEST; MALE; MEGALOBLASTIC ANEMIA; NORTHERN BLOTTING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EDITING; TRANSCOBALAMIN II DEFICIENCY; DNA SEQUENCE; GENETIC DISORDER; GENETICS; INFANT; METABOLISM; SEQUENCE ANALYSIS;

ANEMIA, MEGALOBLASTIC; FEMALE; FIBROBLASTS; GENETIC DISEASES, INBORN; HUMANS; INFANT; MALE; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA EDITING; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, RNA; TRANSCOBALAMINS; VITAMIN B 12;

EID: 0036305322     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2002.0499     Document Type: Article

References (32)

1. Function of transcobalamin II: A B-12 binding protein in human plasma
2. Formation of transcobalamin II-vitamin B12 complex by guinea-pig ileal mucosa in organ culture after in vivo incubation with intrinsic factor-vitamin B12
3. Receptor binding and internalization of immobilized transcobalamin II by mouse leukaemia cells
4. Cobalamin coenzyme synthesis in normal and mutant human fibroblasts. Evidence for a processing enzyme activity deficient in cblC cells
5. Synthesis of cobalamin co-enzymes by human lymphocytes in vitro and the effect of folates and metabolic inhibitors
6. Biochemistry of cobalamins
7. Changes in circulating transcobalamin II after injection of cyanocobalamin
8. Endothelial cells from human umbilical vein secrete functional transcobalamin II
9. Neonatal megaloblastic anemia due to inherited transcobalamin II deficiency in two siblings
10. The neurologic aspects of transcobalamin II deficiency
11. Megaloblastic anemia as a result of an abnormal transcobalamin II (Cardeza)
12. Studies of a patient with megaloblastic anemia and an abnormal transcobalamin II
13. The cDNA sequence and the deduced amino acid sequence of human transcobalamin II show homology with rat intrinsic factor and human transcobalamin I
14. The cloning and characterization of the human transcobalamin II gene
15. Genomic structure of human transcobalamin II: Comparison to human intrinsic factor and transcobalamin I
16. Nonsense mutations in human transcobalamin II deficiency
17. Identification of two mutant alleles of transcobalamin II in an affected family
18. Expression of transcobalamin II mRNA in human tissues and cultured fibroblasts from normal and transcobalamin II-deficient patients
19. Editing of human alpha-galactosidase RNA resulting in a pyrimidine to purine conversion
20. RNA editing in the Wilms' tumor susceptibility gene, WT1
21. Deoxyuridine suppression: Biochemical basis and diagnostic applications
22. Quantitative methods for measurement of transcobalamin II
23. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
24. DNA sequencing with chain-terminating inhibitors
25. Genetic defects of folate and cobalamin metabolism
26. Fidelity of DNA synthesis catalyzed by human DNA polymerase alpha and HIV-1 reverse transcriptase: Effect of reaction pH
27. Recent advances in mammalian RNA editing
28. RNA editing of brain glutamate receptor channels: Mechanism and physiology
29. Apolipoprotein B messenger RNA editing: Insights into the molecular regulation of post-transcriptional cytidine deamination
30. Apolipoprotein B: mRNA editing, lipoprotein assembly, and presecretory degradation
31. RNA editing: Exploring one mode with apolipoprotein B mRNA
32. Safety and efficacy of recombinant human alpha galactosidase-A replacement therapy in Fabry's disease